The Advisory Committee on Immunization Practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines — United States, 2021

Mbaeyi, Sarah; Oliver, Sara E.; Collins, Jennifer P.; Godfrey, Monica; Goswami, Neela D.; Hadler, Stephen C.; Jones, Jefferson; Moline, Heidi; Moulia, Danielle; Reddy, Sujan; Schmit, Kristine; Wallace, Megan; Chamberland, Mary; Campos-Outcalt, Doug; Morgan, Rebecca L.; Bell, Beth P.; Brooks, Oliver; Kotton, Camille; Talbot, H. Keipp; Lee, Grace; Daley, Matthew F.; Dooling, Kathleen

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

The Advisory Committee on Immunization Practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines — United States, 2021

October 29, 2021
By Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; ...
Series: MMWR. Morbidity and mortality weekly report ; v. 70, early release, October 29, 2021

[PDF-374.00 KB]

English

Details Supporting Files You May Also Like

Details:

Personal Author:

Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; Godfrey, Monica ; Goswami, Neela D. ; ... More +

Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; Godfrey, Monica ; Goswami, Neela D. ; Hadler, Stephen C. ; Jones, Jefferson ; Moline, Heidi ; Moulia, Danielle ; Reddy, Sujan ; Schmit, Kristine ; Wallace, Megan ; Chamberland, Mary ; Campos-Outcalt, Doug ; Morgan, Rebecca L. ; Bell, Beth P. ; Brooks, Oliver ; Kotton, Camille ; Talbot, H. Keipp ; Lee, Grace ; Daley, Matthew F. ; Dooling, Kathleen Less -
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; CDC COVID-19 Response Team. ; Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. ; University of Arizona College of Medicine. ; McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. ; ... More +

United States. Advisory Committee on Immunization Practices. ; CDC COVID-19 Response Team. ; Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. ; University of Arizona College of Medicine. ; McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. ; University of Washington. ; Watts Healthcare Corporation. ; Harvard Medical School. ; Vanderbilt University School of Medicine. ; Stanford University School of Medicine. ; Kaiser Permanente Colorado. Institute for Health Research. Less -
Description:

What is already known about this topic? In the United States, three COVID-19 vaccines are approved or authorized for primary vaccination against COVID-19.

What is added by this report? The Advisory Committee on Immunization Practices issued recommendations for an additional primary mRNA COVID-19 vaccine dose for immunocompromised persons and a COVID-19 vaccine booster dose in eligible groups.

What are the implications for public health practice? Health care professionals play a critical role in COVID-19 vaccination efforts, including for primary, additional primary, and booster vaccination, particularly to protect patients who are at increased risk for severe illness and death.

Suggested citation for this article: Mbaeyi S, Oliver SE, Collins JP, et al. The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021. MMWR Morb Mortal Wkly Rep. ePub: 29 October 2021.

mm7044e2.htm?s_cid=mm7044e2_w

mm7044e2-H.pdf
Subjects:

[+]

Advisory Committees Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Immunization, Secondary Vaccination
Series:

MMWR. Morbidity and mortality weekly report ; v. 70, early release, October 29, 2021
Document Type:

Journal Article
Name as Subject:

Pfizer-BioNTech COVID-19 vaccine ; COMIRNATY ; Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Pfizer-BioNTech COVID-19 vaccine ; ... More +

Pfizer-BioNTech COVID-19 vaccine ; COMIRNATY ; Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Pfizer-BioNTech COVID-19 vaccine ; COMIRNATY ; Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine Less -
Place as Subject:

United States
Location:

North America
Pages in Document:

8 numbered pages
Volume:

70
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:a2ec7db9a86e53bc770dc9b412114078cb632af8f6f6b399f7fe7e0fb93aad64
Download URL:

https://stacks.cdc.gov/view/cdc/111114/cdc_111114_DS1.pdf
File Type:

mm7044e2.htm?s_cid=mm7044e2_w

htm

More +